Alterity Therapeutics (ATHE) EBITDA (2016 - 2024)
Alterity Therapeutics (ATHE) recorded quarterly EBITDA of -$12.8 million in Q2 2024, down 36.64% quarter-over-quarter from -$9.3 million in Q2 2023, and down 36.64% on a YoY basis from -$20.1 million in Q3 2023.
Alterity Therapeutics (ATHE) EBITDA (2016 - 2024) Analysis & Trends
Alterity Therapeutics' EBITDA history runs 7 years deep, the most recent figure standing at -$12.8 million for Q2 2024.
- In Q2 2024, EBITDA fell 36.64% year-over-year to -$12.8 million; the TTM figure through Jun 2024 stood at -$12.8 million (down 36.64% YoY), while the FY2025 annual figure was -$7.7 million, up 39.35% from the prior year.
- EBITDA was -$12.8 million for Q2 2024 at Alterity Therapeutics, down from -$9.3 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$9.3 million in Q2 2022 to a low of -$12.8 million in Q2 2024.
- Historically, EBITDA has averaged -$10.5 million across 3 years, with a median of -$9.3 million in 2023.
- The sharpest annual moves came in 2023 and 2024: EBITDA dropped 0.1% in 2023, then tumbled 36.64% in 2024.
- A 3-year view of EBITDA shows it stood at -$9.3 million in 2022, then slipped by 0.1% to -$9.3 million in 2023, then sank by 36.64% to -$12.8 million in 2024.
- The last three EBITDA figures came in at -$12.8 million (Q2 2024), -$9.3 million (Q2 2023), and -$9.3 million (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 661.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -12.76 Mn |
| Jun 30, 2023 | -9.34 Mn |
| Jun 30, 2022 | -9.33 Mn |
| Dec 31, 2019 | -3.85 Mn |
| Jun 30, 2019 | -8.82 Mn |
| Dec 31, 2018 | -3.83 Mn |
| Jun 30, 2018 | -6.38 Mn |
| Dec 31, 2017 | -2.78 Mn |
| Jun 30, 2017 | -5.38 Mn |
| Dec 31, 2016 | -2.74 Mn |